Tonghua Dongbao Pharmaceutical Co., Ltd. (SHA:600867)

China flag China · Delayed Price · Currency is CNY
8.93
-0.11 (-1.22%)
At close: Mar 9, 2026
18.75%
Market Cap 17.36B
Revenue (ttm) 2.74B
Net Income (ttm) 1.23B
Shares Out 1.94B
EPS (ttm) 0.63
PE Ratio 14.24
Forward PE 34.35
Dividend 0.25 (2.77%)
Ex-Dividend Date Jun 25, 2025
Volume 30,069,253
Average Volume 35,762,987
Open 8.98
Previous Close 9.04
Day's Range 8.89 - 9.00
52-Week Range 7.00 - 9.67
Beta 0.39
RSI 53.62
Earnings Date Apr 20, 2026

About SHA:600867

Tonghua Dongbao Pharmaceutical Co., Ltd. researches, develops, produces, and markets pharmaceuticals in China. It offers human insulin injections; insulin glargine injections; insulin aspart injections; liraglutide injections; and proprietary Chinese medicine. The company also provides insulin pen and pen needles; and chronic disease management platform, a diabetes management platform for drug treatment, blood glucose monitoring, and patient education. In addition, it offers chemical drugs, such as repaglinide, sitagliptin phosphate, and metfor... [Read more]

Sector Healthcare
Founded 1985
Employees 3,410
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 600867
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.